OBJECTIVES: Provisions in the Affordable Care Act (ACA) are likely to expand access to substance use disorder treatment for low-income individuals. The aim of the study was to provide information on the need for substance use disorder treatment among individuals who may be eligible for Medicaid under the ACA. METHODS: The 2008 and 2009 National Survey on Drug Use and Health provided data on demographic characteristics, health status, and substance use disorders for comparison of current low-income Medicaid enrollees (N=3,809) with currently uninsured individuals with household incomes that may qualify them for Medicaid coverage beginning in 2014 (N=5,049). The incomes of the groups compared were 138% of the federal poverty level (133% provided in the ACA plus a 5% income "disregard" allowed by the law). RESULTS: The rate of substance use disorders among currently uninsured income-eligible individuals was slightly higher than the rate among current Medicaid enrollees (14.6% versus 11.5%, p=.03). Although both groups had significant unmet need for substance use disorder treatment, the treatment rate among those who needed treatment was significantly lower in the income-eligible group than in the currently enrolled group (31.3% versus 46.8%, p<.01). When the analysis excluded informal care received outside the medical sector, treatment rates among those with treatment needs were much lower in both groups (12.8% in the income-eligible group and 30.7% among current enrollees). CONCLUSIONS: Findings suggest that Medicaid insurance expansions under the ACA will reduce unmet need for substance use disorder treatment.
OBJECTIVES: Provisions in the Affordable Care Act (ACA) are likely to expand access to substance use disorder treatment for low-income individuals. The aim of the study was to provide information on the need for substance use disorder treatment among individuals who may be eligible for Medicaid under the ACA. METHODS: The 2008 and 2009 National Survey on Drug Use and Health provided data on demographic characteristics, health status, and substance use disorders for comparison of current low-income Medicaid enrollees (N=3,809) with currently uninsured individuals with household incomes that may qualify them for Medicaid coverage beginning in 2014 (N=5,049). The incomes of the groups compared were 138% of the federal poverty level (133% provided in the ACA plus a 5% income "disregard" allowed by the law). RESULTS: The rate of substance use disorders among currently uninsured income-eligible individuals was slightly higher than the rate among current Medicaid enrollees (14.6% versus 11.5%, p=.03). Although both groups had significant unmet need for substance use disorder treatment, the treatment rate among those who needed treatment was significantly lower in the income-eligible group than in the currently enrolled group (31.3% versus 46.8%, p<.01). When the analysis excluded informal care received outside the medical sector, treatment rates among those with treatment needs were much lower in both groups (12.8% in the income-eligible group and 30.7% among current enrollees). CONCLUSIONS: Findings suggest that Medicaid insurance expansions under the ACA will reduce unmet need for substance use disorder treatment.
Authors: Jacqueline W Miller; Joseph C Gfroerer; Robert D Brewer; Timothy S Naimi; Ali Mokdad; Wayne H Giles Journal: Am J Prev Med Date: 2004-10 Impact factor: 5.043
Authors: Shelly F Greenfield; Audrey J Brooks; Susan M Gordon; Carla A Green; Frankie Kropp; R Kathryn McHugh; Melissa Lincoln; Denise Hien; Gloria M Miele Journal: Drug Alcohol Depend Date: 2006-06-08 Impact factor: 4.492
Authors: Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser Journal: Health Serv Res Date: 2006-02 Impact factor: 3.402
Authors: Victor A Capoccia; Kyle L Grazier; Christopher Toal; James H Ford; David H Gustafson Journal: Health Aff (Millwood) Date: 2012-05 Impact factor: 6.301
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: R C Kessler; G Andrews; L J Colpe; E Hiripi; D K Mroczek; S L T Normand; E E Walters; A M Zaslavsky Journal: Psychol Med Date: 2002-08 Impact factor: 7.723
Authors: Chandler McClellan; Johanna Catherine Maclean; Brendan Saloner; Emma E McGinty; Michael F Pesko Journal: Health Econ Date: 2020-04-22 Impact factor: 3.046
Authors: Ramin Mojtabai; Kenneth A Feder; Marc Kealhofer; Noa Krawczyk; Carla Storr; Kayla N Tormohlen; Andrea S Young; Mark Olfson; Rosa M Crum Journal: J Subst Abuse Treat Date: 2018-04-04
Authors: Julia Thornton Snider; Margaret E Duncan; Mugdha R Gore; Seth Seabury; Alison R Silverstein; Mahlet G Tebeka; Dana P Goldman Journal: JAMA Netw Open Date: 2019-04-05
Authors: Marguerite E Burns; Laura Dague; Brendan Saloner; Kristen Voskuil; Nam Hyo Kim; Natalia Serna Borrero; Kevin Look Journal: Health Serv Res Date: 2020-06-23 Impact factor: 3.402
Authors: Ellen Meara; Ezra Golberstein; Rebecca Zaha; Shelly F Greenfield; William R Beardslee; Susan H Busch Journal: JAMA Psychiatry Date: 2014-04 Impact factor: 21.596